2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl acetate, 98%, 250mg

5,6-dimethyl-2-(pyridin-2-yl)-1,4-dihydropyrimidin-4-one, 95%, 1g

(2R)-4,4-Difluoropyrrolidine-2-carboxylic acid, 97%, 10g

4-Hydroxyindole, 98.0%, 25g

2-[1-(3-methoxyphenyl)cyclopropyl]acetic acid, >95%, 1g

D-Leucine, min.99%, pour la biochimie, 100 g, emballage plastique.

1-Boc-5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, 95.0%, 10g

2-Fluorophenethyl alcohol, 99.0%, 10g

trans-1,2-Di(2-thienyl)ethylene>98.0%(GC)1g

3,6-dimethylisoxazolo[5,4-d]pyrimidin-4(5H)-one, 95.0%, 250mg

N-(6-Bromopyridin-2-yl)acetamide, 95.0%, 5g

[(3,4-dichlorophenyl)methyl](propyl)amine, 95.0%, 10g

2-Benzoxazol-2-yl-1-(3-trifluoromethylphenyl)ethanol, 97.0%, 5g